Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate

Author: Benzinga Newsdesk | May 02, 2024 04:27pm

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $10.030 million which missed the analyst consensus estimate of $17.431 million by 42.46 percent. This is a 71.81 percent decrease over sales of $35.578 million the same period last year.

Posted In: ZYME